Attar A, Lémann M, Ferguson A, Halphen M, Boutron MC, Flourié B, et al. Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut. 1999 Feb 1;44(2):226–30.
Belsey JD, Geraint M, Dixon TA. Systematic review and meta analysis: polyethylene glycol in adults with non-organic constipation. Int J Clin Pract. 2010 Jun;64(7):944–55.
Candy DCA, Edwards D, Geraint M. Treatment of faecal impaction with polyethylene glycol plus electrolytes (PGE + E) followed by a double-blind comparison of PEG + E versus lactulose as maintenance therapy. J Pediatr Gastroenterol Nutr. 2006 Jul;43(1):65–70.
Chen C-C, Su M-Y, Tung S-Y, Chang F-Y, Wong J-M, Geraint M. Evaluation of polyethylene glycol plus electrolytes in the treatment of severe constipation and faecal impaction in adults. Curr Med Res Opin. 2005 Oct;21(10):1595–602.
Christie AH, Culbert P, Guest JF. Economic impact of low dose polyethylene glycol 3350 plus electrolytes compared with lactulose in the management of idiopathic constipation in the UK. Pharmacoeconomics. 2002;20(1):49–60.
Cinca R, Chera D, Gruss H-J, Halphen M. Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation - a comparison in a controlled environment. Aliment Pharmacol Ther. 2013 May;37(9):876–86.
Constipation in Children and Young People Diagnosis and Management of Idiopathic Childhood Constipation in Primary and Secondary Care. NICE Clinical Guidelines, No. 99. National Collaborating Centre for Women's and Children's Health (UK).London: RCOG Press; 2010. (http://www.nice.org.uk/guidance/CG99)
Eichhorn TE, Oertel WH. Macrogol 3350/Electrolyte Improves Constipation in Parkinson’s Disease and Multiple System Atrophy. Movement Disorders. 2001 Nov 27;16(6):1176–7.
Gruss H, Ulm G. Efficacy and tolerability of PEG 3350 plus electrolytes (Movicol®) in chronic constipation associated with Parkinson’s disease. European Journal of Geriatrics. 2004; 6(3): 143–150.
Guest JF, Clegg JP. Modelling the costs and consequences of treating paediatric faecal impaction in Australia. Curr Med Res Opin. 2006 Jan;22(1):107–19.
Hanson S, Bansal N. The clinical effectiveness of Movicol in children with severe constipation: an outcome audit. Paediatr Nurs. 2006 Mar;18(2):24–8.
Hardikar W, Cranswick N, Heine RG. Macrogol 3350 plus electrolytes for chronic constipation in children: a single-centre, open-label study. J Paediatr Child Health. 2007 Jul;43(7-8):527–31.
Kalke YB, et al, Study to assess the efficacy, safety and tolerability of Macorgol 3350 plus electrolytes (Movicol) to manage the treatment of bowel dysfunction in patients with spinal cord injuries/diseases, Deutschsprachige Medizinische Gesellschaft fur Paraplegie Congress 30 May- 01 June 2002, Basel, Switzerland.
Lee-Robichaud H, Thomas K, Morgan J, Nelson RL. Lactulose versus Polyethylene Glycol for Chronic Constipation. Cochrane Database of Systematic Reviews 2010, Issue 7. Art. No.: CD007570. DOI: 10.1002/14651858.CD007570.pub2.
Madsen L, Magor C, Parker BA. Comparison of two bowel treatments to prevent constipation in post-surgical orthopaedic patients. International Journal of Orthopaedic and Trauma Nursing. 2010 May 1;14(2):75–81.
Migeon-Duballet I, Chabin M, Gautier A, Mistouflet T, Bonnet M, Aubert JM, et al. Long-term efficacy and cost-effectiveness of polyethylene glycol 3350 plus electrolytes in chronic constipation: a retrospective study in a disabled population. Curr Med Res Opin. 2006 Jun;22(6):1227–35.
MOVICOL TGA approved Product Information. December 2011.
Ramkumar D and Rao SSC, Efficacy and safety of traditional medical therapies for chronic constipation: systematic review, American Journal of Gastroenterology 2005; 100: 936-971.
Thomson MA, Jenkins HR, Bisset WM, Heuschkel R, Kalra DS, Green MR, et al. Polyethylene glycol 3350 plus electrolytes for chronic constipation in children: a double blind, placebo controlled, crossover study. Arch Dis Child. 2007 Nov;92(11):996–1000.
Ungar A. Movicol in treatment of constipation and faecal impaction. Hosp Med. 2000 Jan;61(1):37–40.
van der Spoel JI, Oudemans-van Straaten HM, Kuiper MA, van Roon EN, Zandstra DF, van der Voort PHJ. Laxation of critically ill patients with lactulose or polyethylene glycol: a two-center randomized, double-blind, placebo-controlled trial. Crit Care Med. 2007 Dec;35(12):2726–31.
Wang H-J, Liang X-M, Yu Z-L, Zhou L-Y, Lin S-R, Geraint M. A Randomised, Controlled Comparison of Low-Dose Polyethylene Glycol 3350 plus Electrolytes with Ispaghula Husk in the Treatment of Adults with Chronic Functional Constipation. Clin Drug Investig. 2004;24(10):569–76.
Wirz S and Klaschik E, Assessing efficacy of laxatives in palliative care patients receiving opioid therapy with special attention to macrogol + electrolytes, American Journal of Hospice & Palliative Medicine 2005; 22(5): 375-381.
MOVICOL® does not have any links with these third parties.
Any information provided by this source should be discussed with your healthcare professional and does not replace their advice.
We are providing links to third-party websites solely as a convenience to you, because we believe that these websites may provide useful content.
By clicking to continue, you acknowledge and agree to everything we say above.
You are now leaving our website.
You are about to enter the healthcare professionals ONLY site. By clicking YES you confirm that you are a doctor, nurse, or other healthcare professional practising in Australia.